ASBPW

Aspire Biopharma Holdings, Inc. Warrant
ASBPW

Overview Fund Activity

35 hedge funds and large institutions have $2.63M invested in Aspire Biopharma Holdings, Inc. Warrant in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
3
Closed
1
Calls
$2.12M
Puts
–
Net Calls
+$2.12M
Net Calls Change
+$13K

Top Buyers

1
CM
Cohanzick Management
New York
$6.97K
2
SFM
Spartan Fund Management
Canada
$7.82K
3
PC
Periscope Capital
Ontario, Canada
$60.1K
4
FSI
Flow State Investments
Illinois
$2.3K

Top Sellers

1
MP
Mangrove Partners
Connecticut
$657K
2
HCM
Highbridge Capital Management
New York
$4K
3
CS
Clear Street
New York
$2.34K
4
CH
CVI Holdings
Delaware
$0
5
AA
AQR Arbitrage
Connecticut
$27.2K
Name Holding Trade Value Shares
Change 		Shares
Change %
CCM
26
CAAS Capital Management
New York
$3.14K – – –
DCM
27
Difesa Capital Management
New York
$3.14K – – –
PMAM
28
Picton Mahoney Asset Management
Ontario, Canada
$3K – – –
CS
29
Clear Street
New York
$2.34K -$4.06K -97,194 -63%
FSI
30
Flow State Investments
Illinois
$2.3K +$207 +4,951 +10%
ACM
31
Atalaya Capital Management
New York
$2K – – –
OAC
32
OMERS Administration Corp
Ontario, Canada
$1.05K – – –
MTCM
33
Mint Tower Capital Management
Netherlands
$1K – – –
PI
34
PEAK6 Investments
Illinois
$523 – – –
BI
35
Bulldog Investors
New Jersey
$523 – – –
CH
36
CVI Holdings
Delaware
– -$1.97K -24,600 Closed
1
2